Dr Frances Guyett to head NZ innovation hub

Updated on 13 December 2012

The hub, set up earlier this year, has been established to help nurture and grow New Zealand's health technology industry and to support the widespread adoption of leading innovations from public sector

frances-guyett

Dr Frances Guyett

Singapore: New Zealand Health Innovation Hub has appointed Dr Frances Guyett as its chief executive. "After an extensive international search, I am delighted to announce the appointment of Dr Frances Guyett to the position of inaugural chief executive of the New Zealand Health Innovation Hub," said Dr Murray Horn, chairman of the hub.

The New Zealand Health Innovation Hub, set up earlier this year, has been established to help nurture and grow New Zealand's health technology industry and to support the widespread adoption of leading innovations developed within the public health sector.

Dr Guyett has been working with the RMIT University Science, Engineering and Health College as director, Industry Engagement and Commercialization in Melbourne. Prior to that role, she spent six years as chief executive of RDDT Laboratories in Melbourne. RDDT Laboratories is a research organization providing services to the biotechnology, pharmaceutical and chemical industries specializing in medical devices, oncology, cardiovascular and dermatology research.

She has held other senior industry appointments in business development and pharmaceutical companies in Australia, Japan, Europe, the US and Latin American countries.

"We are very fortunate to have secured the services of someone with such an exemplary track record and proven experience. Frances' strong technical background in emerging technologies and research in aligned fields along with her international business expertise in global markets gives me confidence she will provide the Hub with strong leadership," said Mr Horn.

 

Previous 1

Leave a Reply

Post Comment

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X